𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ursodeoxycholic acid therapy for chronic type C hepatitis: A multicenter, dose-finding trial

✍ Scribed by Hajime Takikawa; Masami Yamanaka; Kazuhiko Miyake; Makoto Kako; Hidenori Ohki; Tohru Narita; Fumio Sugata; Makoto Yoshiba; Kazuhiko Sekiyama; Toshio Aoyagi; Hiroshi Nakajima; Kazuo Kamii; Kazunori Matsumoto

Book ID
117090432
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
347 KB
Volume
55
Category
Article
ISSN
0011-393X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A multicenter randomized controlled dose
A multicenter randomized controlled dose study of ursodeoxycholic acid for chronic hepatitis C
✍ Susumu Takano; Yoshimi Ito; Osamu Yokosuka; Masao Ohto; Katsuo Uchiumi; Katsutar πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 663 KB

## AND MASAO OMATA~ The effect of ursodeoxycholic acid on liver function tests and on bile acid metabolism was investigated in a multi-center randomized controlled dose study for chronic hepatitis C. Twenty, 18 and 19 patients were administered 150, 600 and 900 mglday, respectively of ursodeoxycho

Ursodeoxycholic acid as adjunctive thera
Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: A randomized placebo-controlled treatment trial
✍ Albert J. Czaja; Herschel A. Carpenter; Keith D. Lindor πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 1 views

To evaluate the efficacy of ursodeoxycholic acid as adjunctive therapy in type 1 autoimmune hepatitis, 37 patients who had experienced treatment failure, repeated relapse, or incomplete response were randomized to ursodeoxycholic acid (13-15 mg/kg daily) or placebo for 6 months in addition to their